Following the release of the Departments of Labor, Health and Human Services (HHS) and the Treasury (collectively, the Departments) FAQ Part 51, a significant number of unanswered questions remain regarding the coverage of over-the-counter (OTC) COVID-19 tests.

In addition, we are seeing insurance carriers, third-party administrators (TPAs) and pharmacy benefit managers (PBMs) implement solutions that differ based on varying interpretations of the guidance, which can create additional confusion for plan sponsors, who must make decisions regarding how their plans should be amended to comply with the new coverage requirements.

In this webinar, the Brown & Brown Regulatory and Legislative Strategy Group discusses some frequently asked questions. The team outlines questions where some guidance may exist and questions that will require further clarification from the Departments.

Nick Karls

Vice President of Regulatory and Legislative Strategy

Dan Brady

Regulatory and Legislative Specialist

Jessie Campbell

Principal